ArticleCancer research and treatment2024

GASTric Cancer HER2 Re-Assessment Study 2 (GASTHER2): HER2 Re-assessment for Initially HER2-Negative Advanced Gastric Cancer Patients after Progression on First-Line Treatment.

Jaewon Hyung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.